Global Considerations for CAPA from Mock Findings Across US, EU and UK Inspections
Global Considerations for CAPA from Mock Findings Across US, EU and UK Inspections In the competitive landscape of clinical trials, particularly with the focus on pivotal studies like those associated with lecanemab clinical trial, maintaining compliance with regulatory frameworks is critical. Corrective and Preventive Action (CAPA) serves as an essential mechanism fostering quality and regulatory…
Read More “Global Considerations for CAPA from Mock Findings Across US, EU and UK Inspections” »